Hybrid phenotypes and lineage promiscuity in acute leukemia - PubMed (original) (raw)
Review
. 1991 May-Jun;76(3):215-25.
Affiliations
- PMID: 1743592
Review
Hybrid phenotypes and lineage promiscuity in acute leukemia
F Lo Coco. Haematologica. 1991 May-Jun.
Abstract
Clinical data indicate that AL are heterogeneous diseases with variable responsiveness to chemotherapeutic agents. Based on this evidence, the efforts of most investigators are aimed at providing rapid identification of AL features predictive of distinct prognostic outcomes. A considerable number of reagents (including MoAb and molecular probes) available from commercial sources has been widely used for diagnostic purpose, leading to the identification of "inappropriate" antigen expression and to diagnoses of "mixed" AL (M-AL). The latter still lacks adequate definition and identification criteria, but is frequently reported as a novel entity associated with poor clinical outcome. The use of more accurate methodologic approaches, as well as a better elucidation of normal hemopoietic cell characteristics suggest that true M-AL occur quite rarely: the features of normal precursor counterparts are more frequently conserved. "Ectopic" marker expression, however, which should not be interpreted as reflecting lineage infidelity, may in some instances explain different clinical courses in AL patients. Further elucidation of normal stem cell features, and adequate standardization of AL immunophenotyping--to be performed under proper technical conditions--are needed for a better evaluation of M-AL, both in terms of diagnosis and classification, as well as regarding their clinical significance.
Similar articles
- Clinical features and biological implications of acute mixed lineage (hybrid) leukemias.
Altman AJ. Altman AJ. Am J Pediatr Hematol Oncol. 1990 Summer;12(2):123-33. Am J Pediatr Hematol Oncol. 1990. PMID: 2198821 Review. - Definition of acute biphenotypic leukemia.
Matutes E, Morilla R, Farahat N, Carbonell F, Swansbury J, Dyer M, Catovsky D. Matutes E, et al. Haematologica. 1997 Jan-Feb;82(1):64-6. Haematologica. 1997. PMID: 9107085 Review. - Adult and childhood acute lymphoblastic leukemia: clinico-biological differences based on CD34 antigen expression.
Cascavilla N, Musto P, D'Arena G, Ladogana S, Matera R, Carotenuto M. Cascavilla N, et al. Haematologica. 1997 Jan-Feb;82(1):31-7. Haematologica. 1997. PMID: 9107079 - CD56+CD7+ stem cell leukemia/lymphoma with D2-Jdelta1 rearrangement.
Yoshida T, Kimura N, Sawada H, Suematsu E, Nagano M, Akiyoshi T, Motomura S, Kikuchi M, Nishimura J, Tamura K. Yoshida T, et al. Intern Med. 1999 Jul;38(7):547-55. Intern Med. 1999. PMID: 10435360 - Clonal development of the acute leukemias.
Fialkow PJ, Raskind WR, Singer JW, Dow LW, Najfeld V, Veith R. Fialkow PJ, et al. Bone Marrow Transplant. 1989 Jan;4 Suppl 1:76-8. Bone Marrow Transplant. 1989. PMID: 2653523 Review. No abstract available.
Cited by
- Chromosomal abnormality of acute promyelocytic leukemia other than _PML_-RARA: a case report of acute promyelocytic leukemia with del(5q).
Imataki O, Uemura M. Imataki O, et al. BMC Clin Pathol. 2016 Oct 4;16:16. doi: 10.1186/s12907-016-0038-4. eCollection 2016. BMC Clin Pathol. 2016. PMID: 27708545 Free PMC article. - Prognosis of children with mixed phenotype acute leukemia treated on the basis of consistent immunophenotypic criteria.
Mejstrikova E, Volejnikova J, Fronkova E, Zdrahalova K, Kalina T, Sterba J, Jabali Y, Mihal V, Blazek B, Cerna Z, Prochazkova D, Hak J, Zemanova Z, Jarosova M, Oltova A, Sedlacek P, Schwarz J, Zuna J, Trka J, Stary J, Hrusak O. Mejstrikova E, et al. Haematologica. 2010 Jun;95(6):928-35. doi: 10.3324/haematol.2009.014506. Epub 2010 Feb 9. Haematologica. 2010. PMID: 20145275 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical
Research Materials